# Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas

> **NCT05259332** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 85 (estimated)

## Conditions studied

- Meningioma Atypical

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05259332
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-25
- **Primary completion:** 2022-04-01
- **Final completion:** 2023-10-31
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2022-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05259332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05259332, "Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05259332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*